Physician profile
Blake B Bechtle
NPI 1386356657
$1,067.87
in general payments reported to CMS, 2019-2025
15 companies · $498 in 2025
The $498 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $104 · 2024: $466 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $506.11 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $162.94 | 2024-2025 | |
| Novo Nordisk INC | $73.09 | 2024-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $66.55 | 2024-2025 | Zepbound, Mounjaro |
| Medtronic, INC. | $38.61 | 2025 | Inceptiv |
| Amgen INC. | $28.61 | 2023 | Repatha |
| Phathom Pharmaceuticals, INC. | $26.05 | 2024-2025 | Voquezna |
| Exeltis, USA INC. | $24.48 | 2025 | Slynd |
| Abbott Laboratories | $24.43 | 2025 | Freestyle Libre 3 |
| Pfizer INC. | $23.77 | 2025 | |
| Glaxosmithkline, LLC. | $21.01 | 2025 | Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $20.08 | 2024 | Spravato |
| Corcept Therapeutics | $19.43 | 2024 | Korlym |
| Idorsia Pharmaceuticals US INC | $17.53 | 2023 | Quviviq |
| Hologic Sales and Service, LLC | $15.18 | 2024 | Thinprep 2000 Processor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Bechtle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.